Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: A community-based study

Journal of Hepatology

Volumn 49, Issue 1, 2008, Pages 9-16

  Dai, Chia Yen ^a,b   Chuang, Wan Long ^a,b   Ho, Chi Kung ^a   Hsieh, Ming Yen ^a   Huang, Jee Fu ^a,c   Lee, Li Po ^a   Hou, Nai Jen ^a,c   Lin, Zu Yau ^a,b   Chen, Shinn Cherng ^a,b   Hsieh, Ming Yuh ^a,b   Wang, Liang Yen ^a,b   Tsai, Jun Fa ^a,b   Chang, Wen Yu ^a,b   Yu, Ming Lung ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

anti HCV; Cholesterol; HCV RNA; Triglyceride; Viremia

Indexed keywords

CHOLESTEROL; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; TRIACYLGLYCEROL; VIRUS RNA;

ADULT; ARTICLE; AUTOANALYSIS; BLOOD CHEMISTRY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RNA ANALYSIS; STANDARDIZATION; STATISTICAL SIGNIFICANCE; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL; VIREMIA;

CHOLESTEROL; ENDEMIC DISEASES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS B; HEPATITIS C; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RESIDENCE CHARACTERISTICS; RISK FACTORS; RNA, VIRAL; TAIWAN; TRIGLYCERIDES; VIREMIA;

EID: 44649166337     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.03.016     Document Type: Article

References (31)

1. Mazzaro C., Panarello G., Tesio F., Santini G., Crovatto M., Mazzi G., et al. Hepatitis C virus risk: a hepatitis C virus related syndrome. J Intern Med 247 (2000) 535-545
2. Hadziyannis S.J. The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepatitis 4 (1997) 9-28
3. Congia M., Clemente M.G., Dessi C., Cucca F., Mazzoleni A.P., Frau F., et al. HLA class II genes in chronic hepatitis C virus - infection and associated immunological disorders. Hepatology 24 (1996) 1338-1341
4. Streiff M.B., Mehta S., and Thomas D.L. Peripheral blood count abnormalities among patients with hepatitis C in the United States. Hepatology 35 (2002) 947-952
5. Mason A.L., Lau J.Y., Hoang N., Qian K., Alexander G.J., Xu L., et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29 (1999) 328-333
6. Shintani Y., Fujie H., Miyoshi H., Tsutsumi T., Tsukamoto K., Kimura S., et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126 (2004) 840-848
7. Mehta S.H., Brancati F.L., Sulkowski M.S., Strathdee S.A., Sklo M., and Thomas D.L. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 133 (2000) 592-599
8. Thomssen R., Bonk S., Propfe C., Heermann K.H., Kochel H.G., and Uy A. Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol (Berl) 181 (1992) 293-300
9. Monazahian M., Kippenberger S., Muller A., Seitz H., Bohme I., Grethe S., et al. Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus. Med Microbiol Immunol (Berl) 188 (2000) 177-184
10. Perlemuter G., Sabile A., Letteron P., Vona G., Topilco A., Chretien Y., et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 16 (2002) 185-194
11. Serfaty L., Andreani T., Giral P., Carbonell N., Chazouillères O., and Poupon R. Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol 34 (2001) 428-434
12. Shonfeld G. The hypobetalipoproteinemias. Ann Rev Nutr 15 (1995) 23-34
13. Fabris C., Federico E., Soardo G., Falleti E., and Pirisi M. Blood lipids of patients with chronic hepatitis: differences related to viral etiology. Clin Chim Acta 261 (1997) 159-165
14. Siagris D., Christofidou M., Theocharis G.J., Pagoni N., Papadimitriou C., Lekkou A., et al. Serum lipid pattern in chronic hepatitis C: histological and virological correlations. J Viral Hepat 13 (2006) 56-61
15. Marzouk D., Sass J., Bakr I., El Hoseiny M., Abdel-Hamid M., Rekacewicz C., et al. Metabolic liver disease and HCV infection in rural Egypt. Gut 56 (2007) 1105-1110
16. Moriya K., Shintani Y., Fujie H., Miyoshi H., Tsutsumi T., Yotsuyanagi H., et al. Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan. Hepatol Res 25 (2003) 371-376
17. Chuang W.L., Yu M.L., Dai C.Y., and Chang W.Y. Treatment of chronic hepatitis C in southern Taiwan. Intervirology 49 (2006) 99-106
18. Wang J.H., Lu S.N., Wu J.C., Huang J.F., Yu M.L., Chen S.C., et al. A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan. Trans R Soc Trop Med Hyg 93 (1999) 253-254
19. Yu M.L., Chuang W.L., Chen S.C., Dai C.Y., Hou C., Wang J.H., et al. Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan. J Med Virol 65 (2001) 58-65
20. Huang J.F., Chuang W.L., Dai C.Y., Ho C.K., Hwang S.J., Chen S.C., et al. Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?. J Intern Med 260 (2006) 255-262
21. Dai C.Y., Huang J.F., Hsieh M.Y., Lee L.P., Ho C.K., Chang W.Y., et al. The role of gender on clearance of hepatitis C virus: a different story in a hepatitis B and C endemic area?. Gut 56 (2007) 737-738
22. Okamoto H., Tokita H., Sakamoto M., Horikita M., Kojima M., Iizuka H., et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 74 (1993) 2385-2389
23. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
24. Maggi G., Bottelli R., Gola D., Perricone G., Posca M., Zavaglia C., et al. Serum cholesterol and chronic hepatitis C. Ital J Gastroenterol 28 (1996) 436-440
25. Agnello V., Abel G., Elfahal M., Knight G.B., and Zhang Q.X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 96 (1999) 12766-12771
26. Petit J.M., Benichou M., Duvillard L., Jooste V., Bour J.B., Minello A., et al. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis. Am J Gastroenterol 98 (2003) 1150-1154
27. Shi S.T., Polyak S.J., Tu H., Taylor D.R., Gretch D.R., and Lai M.M. Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 292 (2002) 198-210
28. Barba G., Harper F., Harada T., Kohara M., Goulinet S., Matsuura Y., et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 94 (1997) 1200-1205
29. Leandro G., Mangia A., Hui J., Fabris P., Rubbia-Brandt L., Colloredo G., et al. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 130 (2006) 1636-1642
30. Kono Y., Hayashida K., Tanaka H., Ishibashi H., and Harada M. High-density lipoprotein binding rate differs greatly between genotypes 1b and 2a/2b of hepatitis C virus. J Med Virol 70 (2003) 42-48
31. Okamoto H., and Mishiro S. Genetic heterogeneity of hepatitis C virus. Intervirology 37 (1994) 68-76